CN100431515C - 稳定微粒化药物添加剂的制备方法 - Google Patents
稳定微粒化药物添加剂的制备方法 Download PDFInfo
- Publication number
- CN100431515C CN100431515C CNB2005100498060A CN200510049806A CN100431515C CN 100431515 C CN100431515 C CN 100431515C CN B2005100498060 A CNB2005100498060 A CN B2005100498060A CN 200510049806 A CN200510049806 A CN 200510049806A CN 100431515 C CN100431515 C CN 100431515C
- Authority
- CN
- China
- Prior art keywords
- microgranule
- gross weight
- particles
- material gross
- corn starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 51
- 239000000654 additive Substances 0.000 title claims abstract description 40
- 230000000996 additive effect Effects 0.000 title claims abstract description 38
- 238000000034 method Methods 0.000 title claims abstract description 17
- 229940079593 drug Drugs 0.000 title claims description 21
- 239000000463 material Substances 0.000 claims abstract description 97
- 239000007788 liquid Substances 0.000 claims abstract description 64
- 239000000843 powder Substances 0.000 claims abstract description 57
- 239000007921 spray Substances 0.000 claims abstract description 51
- 238000002156 mixing Methods 0.000 claims abstract description 31
- 238000002360 preparation method Methods 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 230000009471 action Effects 0.000 claims abstract description 20
- 239000011230 binding agent Substances 0.000 claims abstract description 12
- 239000004531 microgranule Substances 0.000 claims description 156
- 229920002261 Corn starch Polymers 0.000 claims description 50
- 239000008120 corn starch Substances 0.000 claims description 50
- 239000008187 granular material Substances 0.000 claims description 47
- 229920001353 Dextrin Polymers 0.000 claims description 31
- 239000004375 Dextrin Substances 0.000 claims description 31
- 235000019425 dextrin Nutrition 0.000 claims description 31
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 28
- 229930006000 Sucrose Natural products 0.000 claims description 28
- 239000005720 sucrose Substances 0.000 claims description 28
- 238000005243 fluidization Methods 0.000 claims description 22
- 239000012530 fluid Substances 0.000 claims description 21
- 238000001035 drying Methods 0.000 claims description 19
- 238000000926 separation method Methods 0.000 claims description 19
- 239000012153 distilled water Substances 0.000 claims description 17
- 150000002333 glycines Chemical class 0.000 claims description 14
- 239000005662 Paraffin oil Substances 0.000 claims description 13
- 229920002472 Starch Polymers 0.000 claims description 11
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 11
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 11
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 11
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 11
- 239000008107 starch Substances 0.000 claims description 11
- 235000019698 starch Nutrition 0.000 claims description 11
- 229950007634 kitasamycin Drugs 0.000 claims description 10
- XYJOGTQLTFNMQG-KJHBSLKPSA-N leucomycin V Chemical compound CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](N(C)C)[C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1 XYJOGTQLTFNMQG-KJHBSLKPSA-N 0.000 claims description 10
- WQGJEAMPBSZCIF-HKSLRPGUSA-N Maduramicin Chemical compound N.O1[C@@H](C)[C@H](OC)[C@@H](OC)C[C@H]1O[C@@H]1[C@H]([C@@]2(C)O[C@H](CC2)[C@@]2(C)O[C@]3(O[C@@H]([C@H](C)[C@@H](O)C3)[C@@H](C)[C@H]3[C@@H]([C@@H](OC)[C@H](C)[C@@](O)(CC(O)=O)O3)OC)CC2)O[C@@H]([C@@H]2[C@H](C[C@@H](C)[C@@](C)(O)O2)C)C1 WQGJEAMPBSZCIF-HKSLRPGUSA-N 0.000 claims description 9
- UKHWDRMMMYWSFL-UHFFFAOYSA-N Nicarbazin Chemical compound CC=1C=C(C)NC(=O)N=1.C1=CC([N+](=O)[O-])=CC=C1NC(=O)NC1=CC=C([N+]([O-])=O)C=C1 UKHWDRMMMYWSFL-UHFFFAOYSA-N 0.000 claims description 9
- 108010019657 polymyxin drug combination nystatin neomycin dimethicone acetarsol Proteins 0.000 claims description 9
- VHKXXVVRRDYCIK-CWCPJSEDSA-N Narasin Chemical compound C[C@H]1C[C@H](C)[C@H]([C@@H](CC)C(O)=O)O[C@H]1[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@@H]1[C@@H](C)C[C@@H](C)[C@@]2(C=C[C@@H](O)[C@@]3(O[C@@](C)(CC3)[C@@H]3O[C@@H](C)[C@@](O)(CC)CC3)O2)O1 VHKXXVVRRDYCIK-CWCPJSEDSA-N 0.000 claims description 7
- VHKXXVVRRDYCIK-UHFFFAOYSA-N Narasin Natural products CC1CC(C)C(C(CC)C(O)=O)OC1C(C)C(O)C(C)C(=O)C(CC)C1C(C)CC(C)C2(C=CC(O)C3(OC(C)(CC3)C3OC(C)C(O)(CC)CC3)O2)O1 VHKXXVVRRDYCIK-UHFFFAOYSA-N 0.000 claims description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 7
- 239000002671 adjuvant Substances 0.000 claims description 7
- 229960001851 narasin Drugs 0.000 claims description 7
- 239000001117 sulphuric acid Substances 0.000 claims description 7
- 235000011149 sulphuric acid Nutrition 0.000 claims description 7
- ZSZFUDFOPOMEET-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-[2,6-dichloro-4-(3,5-dioxo-1,2,4-triazin-2-yl)phenyl]acetonitrile Chemical compound C1=CC(Cl)=CC=C1C(C#N)C1=C(Cl)C=C(N2C(NC(=O)C=N2)=O)C=C1Cl ZSZFUDFOPOMEET-UHFFFAOYSA-N 0.000 claims description 6
- 108010001478 Bacitracin Proteins 0.000 claims description 6
- 239000004182 Tylosin Substances 0.000 claims description 6
- 229930194936 Tylosin Natural products 0.000 claims description 6
- 229960005364 bacitracin zinc Drugs 0.000 claims description 6
- 229960000248 diclazuril Drugs 0.000 claims description 6
- CPEUVMUXAHMANV-UHFFFAOYSA-N flubendazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1C(=O)C1=CC=C(F)C=C1 CPEUVMUXAHMANV-UHFFFAOYSA-N 0.000 claims description 6
- 229960004500 flubendazole Drugs 0.000 claims description 6
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims description 6
- XMVJITFPVVRMHC-UHFFFAOYSA-N roxarsone Chemical compound OC1=CC=C([As](O)(O)=O)C=C1[N+]([O-])=O XMVJITFPVVRMHC-UHFFFAOYSA-N 0.000 claims description 6
- 229960003052 roxarsone Drugs 0.000 claims description 6
- XOIQMTLWECTKJL-FBZUZRIGSA-M sodium;(2s,3r,4s)-4-[(2s,5r,7s,8r,9s)-2-[(2r,5s)-5-ethyl-5-[(2r,3s,5r)-5-[(2s,3s,5r,6r)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate Chemical compound [Na+].C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C([O-])=O)O2 XOIQMTLWECTKJL-FBZUZRIGSA-M 0.000 claims description 6
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 claims description 6
- 235000019375 tylosin Nutrition 0.000 claims description 6
- 229960004059 tylosin Drugs 0.000 claims description 6
- UCRLQOPRDMGYOA-DFTDUNEMSA-L zinc;(4r)-4-[[(2s)-2-[[(4r)-2-[(1s,2s)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2s,3s)-1-[[(3s,6r,9s,12r,15s,18r,21s)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2s)-butan-2-yl]-6-(carbox Chemical compound [Zn+2].C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC([O-])=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2NC=NC=2)C(=O)N[C@H](CC([O-])=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 UCRLQOPRDMGYOA-DFTDUNEMSA-L 0.000 claims description 6
- PERZMHJGZKHNGU-JGYWJTCASA-N bambermycin Chemical compound O([C@H]1[C@H](NC(C)=O)[C@@H](O)[C@@H]([C@H](O1)CO[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1NC(C)=O)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@H](O1)C(=O)NC=1C(CCC=1O)=O)O)C)[C@H]1[C@@H](OP(O)(=O)OC[C@@H](OC\C=C(/C)CC\C=C\C(C)(C)CCC(=C)C\C=C(/C)CCC=C(C)C)C(O)=O)O[C@H](C(O)=O)[C@@](C)(O)[C@@H]1OC(N)=O PERZMHJGZKHNGU-JGYWJTCASA-N 0.000 claims description 5
- 229950007118 bambermycin Drugs 0.000 claims description 5
- 235000019374 flavomycin Nutrition 0.000 claims description 5
- GOVWOKSKFSBNGD-UHFFFAOYSA-N Ethopabate Chemical compound CCOC1=CC(NC(C)=O)=CC=C1C(=O)OC GOVWOKSKFSBNGD-UHFFFAOYSA-N 0.000 claims description 4
- 229940093501 ethopabate Drugs 0.000 claims description 4
- MVVJINIUPYKZHR-UHFFFAOYSA-N 3-[[4-[5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenoxy]methyl]benzonitrile Chemical compound O=C1OC(COC)CN1C(C=C1)=CC=C1OCC1=CC=CC(C#N)=C1 MVVJINIUPYKZHR-UHFFFAOYSA-N 0.000 claims description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 3
- SJUWEPZBTXEUMU-LDXVYITESA-N 7-bromo-6-chloro-3-[3-[(2s,3r)-3-hydroxypiperidin-2-yl]-2-oxopropyl]quinazolin-4-one;hydrobromide Chemical compound Br.O[C@@H]1CCCN[C@H]1CC(=O)CN1C(=O)C2=CC(Cl)=C(Br)C=C2N=C1 SJUWEPZBTXEUMU-LDXVYITESA-N 0.000 claims description 3
- ZDPIZLCVJAAHHR-UHFFFAOYSA-N Clopidol Chemical compound CC1=NC(C)=C(Cl)C(O)=C1Cl ZDPIZLCVJAAHHR-UHFFFAOYSA-N 0.000 claims description 3
- FPTCMHOCGKKRGQ-WYOWUDGCSA-N Multhiomycin Natural products CC=C1NC(=O)[C@@H](NC(=O)c2csc(n2)c3cc(O)c(nc3c4csc(n4)[C@H]5CSC(=O)c6[nH]c7cccc(COC(=O)[C@@H](O)C[C@H](NC(=O)c8csc1n8)c9nc(cs9)C(=O)N5)c7c6C)c%10nc(cs%10)C(=O)N[C@@H](C)C(=O)N)[C@H](C)O FPTCMHOCGKKRGQ-WYOWUDGCSA-N 0.000 claims description 3
- MVTQIFVKRXBCHS-SMMNFGSLSA-N N-[(3S,6S,12R,15S,16R,19S,22S)-3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone Chemical compound CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c2coc(CC(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@H]1C)n2.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O)c1ccccc1 MVTQIFVKRXBCHS-SMMNFGSLSA-N 0.000 claims description 3
- 101800003864 Nosiheptide Proteins 0.000 claims description 3
- 239000004188 Virginiamycin Substances 0.000 claims description 3
- 108010080702 Virginiamycin Proteins 0.000 claims description 3
- 229960000731 clopidol Drugs 0.000 claims description 3
- POUMFISTNHIPTI-BOMBIWCESA-N hydron;(2s,4r)-n-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;chloride Chemical compound Cl.CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 POUMFISTNHIPTI-BOMBIWCESA-N 0.000 claims description 3
- 229960001595 lincomycin hydrochloride Drugs 0.000 claims description 3
- MQWDKYHFGBWGQZ-JQTJYXGUSA-N nosiheptide Chemical compound N([C@H](C(=O)N\C(C=1SC=C(N=1)C(=O)N[C@@H]1CC(O)C(=O)OCC=2C=CC=C3NC(=C(C3=2)C)C(=O)SC[C@H](NC(=O)C=2N=C1SC=2)C=1SC=C(N=1)C1=N2)=C/C)[C@@H](C)O)C(=O)C(N=3)=CSC=3C1=CC(=O)\C2=C1/NC(C(=O)NC(=C)C(N)=O)=CS1 MQWDKYHFGBWGQZ-JQTJYXGUSA-N 0.000 claims description 3
- 229950006423 nosiheptide Drugs 0.000 claims description 3
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 claims description 3
- 229960004306 sulfadiazine Drugs 0.000 claims description 3
- 229960003842 virginiamycin Drugs 0.000 claims description 3
- 235000019373 virginiamycin Nutrition 0.000 claims description 3
- 235000013339 cereals Nutrition 0.000 claims 1
- 229940100486 rice starch Drugs 0.000 claims 1
- 238000005520 cutting process Methods 0.000 abstract description 26
- 239000002245 particle Substances 0.000 abstract description 18
- 239000000428 dust Substances 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 4
- 238000009827 uniform distribution Methods 0.000 abstract description 2
- 238000009423 ventilation Methods 0.000 abstract description 2
- 230000001681 protective effect Effects 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 35
- 238000005469 granulation Methods 0.000 description 19
- 230000003179 granulation Effects 0.000 description 19
- 238000005054 agglomeration Methods 0.000 description 18
- 230000002776 aggregation Effects 0.000 description 18
- 238000011049 filling Methods 0.000 description 16
- 238000010348 incorporation Methods 0.000 description 16
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 14
- 238000005516 engineering process Methods 0.000 description 8
- 235000019359 magnesium stearate Nutrition 0.000 description 7
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 229940085605 saccharin sodium Drugs 0.000 description 6
- 238000003756 stirring Methods 0.000 description 5
- 238000012864 cross contamination Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 239000011885 synergistic combination Substances 0.000 description 4
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 229960005287 lincomycin Drugs 0.000 description 3
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 241000272496 Galliformes Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 231100000643 Substance intoxication Toxicity 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229960002418 ivermectin Drugs 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100498060A CN100431515C (zh) | 2005-05-24 | 2005-05-24 | 稳定微粒化药物添加剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100498060A CN100431515C (zh) | 2005-05-24 | 2005-05-24 | 稳定微粒化药物添加剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1695589A CN1695589A (zh) | 2005-11-16 |
CN100431515C true CN100431515C (zh) | 2008-11-12 |
Family
ID=35348578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100498060A Expired - Fee Related CN100431515C (zh) | 2005-05-24 | 2005-05-24 | 稳定微粒化药物添加剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100431515C (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101273968B (zh) * | 2008-05-06 | 2010-06-09 | 浙江汇能动物药品有限公司 | 马度米星铵固体分散体及其制备方法 |
CN101611766B (zh) * | 2009-07-16 | 2012-06-06 | 无锡正大畜禽有限公司 | 一种饲料用肠溶吉他霉素包衣的生产方法 |
CN102697660B (zh) * | 2012-06-04 | 2014-02-12 | 贵州景峰注射剂有限公司 | 一种去除微丸丸间静电的方法 |
CN104208657B (zh) * | 2014-09-10 | 2016-08-17 | 河南牧翔动物药业有限公司 | 一种维吉尼亚霉素可溶性粉及其制备方法 |
CN105434367A (zh) * | 2016-01-29 | 2016-03-30 | 黄利文 | 一种可溶性尼卡巴嗪预混剂及其制备方法 |
US10694683B2 (en) * | 2017-05-20 | 2020-06-30 | Insectergy, Llc | Cannabis farming systems and methods |
CN108902480A (zh) * | 2018-07-27 | 2018-11-30 | 河南大华生物技术有限公司 | 一种提高饲料中微量添加物均匀度和生物利用度的方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3453368A (en) * | 1966-01-13 | 1969-07-01 | Hoffmann La Roche | Smaller high potency compressed tablets of ascorbic acid |
JPS5215812A (en) * | 1975-07-24 | 1977-02-05 | Takeda Chem Ind Ltd | Process for preparing an l-ascorbic acid pharmaceutical |
JPS5759803A (en) * | 1980-09-30 | 1982-04-10 | Takeda Chem Ind Ltd | Granule of l-sodium ascorbate, its preparation, and tablet comprising it |
CN1065797A (zh) * | 1992-05-22 | 1992-11-04 | 东北第六制药厂二分厂 | 小儿胃宝丸的制造方法 |
CN1068960A (zh) * | 1992-07-25 | 1993-02-17 | 广州白云山制药总厂 | 一种中成药胶囊剂的生产工艺 |
CN1149824A (zh) * | 1994-06-03 | 1997-05-14 | 罗纳-布朗克罗莱尔股份有限公司 | 珠的制法以及含有熔点不确定活性成份的珠状物 |
CN1229356A (zh) * | 1996-09-05 | 1999-09-22 | 武田药品工业株式会社 | 具有优良成片性能的水溶性维生素组合物及其生产方法 |
CN1331583A (zh) * | 1998-10-26 | 2002-01-16 | 田边制药株式会社 | 球状含药细粒的制备方法 |
-
2005
- 2005-05-24 CN CNB2005100498060A patent/CN100431515C/zh not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3453368A (en) * | 1966-01-13 | 1969-07-01 | Hoffmann La Roche | Smaller high potency compressed tablets of ascorbic acid |
JPS5215812A (en) * | 1975-07-24 | 1977-02-05 | Takeda Chem Ind Ltd | Process for preparing an l-ascorbic acid pharmaceutical |
JPS5759803A (en) * | 1980-09-30 | 1982-04-10 | Takeda Chem Ind Ltd | Granule of l-sodium ascorbate, its preparation, and tablet comprising it |
CN1065797A (zh) * | 1992-05-22 | 1992-11-04 | 东北第六制药厂二分厂 | 小儿胃宝丸的制造方法 |
CN1068960A (zh) * | 1992-07-25 | 1993-02-17 | 广州白云山制药总厂 | 一种中成药胶囊剂的生产工艺 |
CN1149824A (zh) * | 1994-06-03 | 1997-05-14 | 罗纳-布朗克罗莱尔股份有限公司 | 珠的制法以及含有熔点不确定活性成份的珠状物 |
CN1229356A (zh) * | 1996-09-05 | 1999-09-22 | 武田药品工业株式会社 | 具有优良成片性能的水溶性维生素组合物及其生产方法 |
CN1331583A (zh) * | 1998-10-26 | 2002-01-16 | 田边制药株式会社 | 球状含药细粒的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1695589A (zh) | 2005-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100431515C (zh) | 稳定微粒化药物添加剂的制备方法 | |
CN1022024C (zh) | 含有维生素的颗粒及其制备方法 | |
EP0305356B1 (en) | Granular product (i) | |
US4489026A (en) | Process for preparing solid unit dosage forms of ultra-low dose drugs | |
CN1177787C (zh) | 粉状甘露糖醇及其制备方法 | |
US8597685B2 (en) | Method for production of particles of pharmaceutical substances particles of pharmaceutical substances and the use thereof | |
US6558704B1 (en) | Process for preparing pellets containing up to 90 wt.% of a pharmaceutical active ingredient | |
WO2001000042A1 (de) | Polymerbeschichtete, granulierte enzymhaltige futtermittelzusätze und verfahren zu deren herstellung | |
JP5537755B2 (ja) | 直接圧縮可能なα型マンニトールの製造方法 | |
EP2834217B1 (en) | Nicotinamide powder and process and device for its production | |
CN102219912B (zh) | 一种颗粒型黄原胶的制备方法 | |
WO1999025343A1 (en) | Granules comprising clavulanate and one or more excipients | |
CN1087185C (zh) | 一种借助于蒸汽聚结水敏物质的方法与设备 | |
KR100595962B1 (ko) | 측쇄 아미노산 함유 과립의 제조방법 | |
JPH06205959A (ja) | 球形顆粒、その製造方法およびそれを用いた医薬品 | |
CN101631549B (zh) | 贴附于口腔粘膜的丁丙诺非制剂的制造方法 | |
CN101219124A (zh) | 盐酸头孢他美酯分散片及其制备方法 | |
CN113975241B (zh) | 琥珀酸曲格列汀片剂的制备工艺 | |
CN101390840B (zh) | 一种能够直接压片的高含量抗坏血酸钙颗粒的生产方法 | |
CN107468655B (zh) | 一种香菇多糖颗粒及其制备方法 | |
CN109481468A (zh) | 一种氨咖黄敏胶囊微丸的制备方法 | |
AU2016254983B2 (en) | Monensin water dispersible granules by wet granulation | |
EP1238673A1 (en) | Colistin sulfate granules | |
EP0041114B1 (en) | Process for the preparation of medicated animal feed supplement | |
CN100438879C (zh) | 制造兽药马杜霉素铵、伊维菌素或地克珠利预混剂的新工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: ZHEJIANG HUIJIA BIOTECHNOLOGY CO., LTD. Assignor: Zhejiang University Contract record no.: 2011330001043 Denomination of invention: Method for preparing additive of stable micronized medication Granted publication date: 20081112 License type: Exclusive License Open date: 20051116 Record date: 20110803 |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081112 Termination date: 20150524 |
|
EXPY | Termination of patent right or utility model |